Cycle-length evidence
Adipotide cycle length: what human studies ran
Not approved — research use onlyCPreclinical research
Short answer: there is no established Adipotide cycle length, and we found no human studies that report one.
Treatment and follow-up in human studies
No human study durations are recorded.
What has not been tested
- On-and-off schedules or breaks between courses.
- Repeated courses and long-term exposure beyond the periods listed.
- Adipotide combined with other compounds, unless a study above says so.
Frequently asked questions
Is there an established Adipotide cycle length?
No. We found no human studies that report a treatment duration for Adipotide.
What is the longest human study of Adipotide?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
References
- Reversal of obesity by targeted ablation of adipose tissue Nat Med. 2004
- A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys Sci Transl Med. 2011
- Rapid and weight-independent improvement of glucose tolerance induced by a peptide designed to elicit apoptosis in adipose tissue endothelium Diabetes. 2012
- Comment on "A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys" Sci Transl Med. 2012
- A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity (NCT01262664) ClinicalTrials.gov. 2019
- Adipotide (CID 163360068) PubChem. 2026
- Drugs@FDA application data queried through openFDA for adipotide (no matching application record returned on 24 October 2026) openFDA / Drugs@FDA. 2026
- International Standard: Prohibited List 2026 World Anti-Doping Agency. 2026